Share
Market Research Report

U.S. PHARMACEUTICAL SPRAY DRYING CDMO SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Service OfferingsStandard Spray Drying Services · Formulation Development + Spray Drying · Spray Dried Dispersion Services · and Others Services
  • By ProductSmall Molecules and APIs · High Potent Active Pharmaceutical Ingredients (HPAPI) · Excipients · Co-Spray Drying/Composite Particle Formation · Controlled Substances · Biologics/Proteins/Peptide · and Others
  • By Operational ScalePilot/Clinical-Scale Services and Commercial/Industrial-Scale Services
  • By Application AreaOral Dosage Forms (powders, granules, or ASD for tablets/capsules) · Injectable/Parenteral · Pulmonary/Inhalation Delivery · Encapsulated Formulations/Co-Spray Dried Particles · and Others (Controlled Release/Sustained Release and Others)
  • By End UserPharmaceutical Companies · Biopharmaceutical/Biotechnology Companies · Academic or Contract Research Organizations · and Others
  • Published In01 Apr 2026
  • Report CodeCMI9040
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Service Offerings Insights (Revenue, USD Mn, 2021 - 2033)

    • Standard Spray Drying Services
    • Formulation Development + Spray Drying
    • Spray Dried Dispersion (SDD) Services
    • Others Services (Scale Up & Tech Transfer & Others)
  • Product Insights (Revenue, USD Mn, 2021 - 2033)

    • Small Molecules and APIs
    • High Potent Active Pharmaceutical Ingredients (HPAPI)
    • Excipients
    • Co-Spray Drying/Composite Particle Formation (API + Excipient)
    • Controlled Substances
    • Biologics/Proteins/Peptide
    • Others (Nutraceutical/Dietary Supplement Powders and Others)
  • Operational Scale Insights (Revenue, USD Mn, 2021 - 2033)

    • Pilot/Clinical-Scale Services
    • Commercial/Industrial-Scale Services
  • Application Area Insights (Revenue, USD Mn, 2021 - 2033)

    • Oral Dosage Forms (powders, granules, or ASD for tablets/capsules)
    • Injectable/Parenteral (intermediate powders for reconstitution)
    • Pulmonary/Inhalation Delivery (dry powders for inhalers)
    • Encapsulated Formulations/Co-Spray Dried Particles
    • Others (Controlled Release/Sustained Release and Others)
  • End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Pharmaceutical Companies
    • Biopharmaceutical/Biotechnology Companies
    • Academic or Contract Research Organizations (CROs)
    • Others (Nutraceutical and Dietary Supplement Companies and Others)